Molecular mechanisms of Streptococcus dysgalactiae subsp equisimilis enabling intravascular persistence

Microbes and Infection

Volumn 14, Issue 4, 2012, Pages 329-334

  Rohde, Manfred ^b   Talay, Susanne R ^b   Rasmussen, Magnus ^a  

^a LUND UNIVERSITY   (Sweden)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Internalization; Intravascular persistence; Platelet aggregation; Recurrent bacteremia

Indexed keywords

BETA ACTIN; FIBRONECTIN;

ANTIBODY ISOLATION; AORTA ANEURYSM; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; ENTEROCOCCUS FAECALIS; FEMALE; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; SEPSIS; STREPTOCOCCUS DYSGALACTIAE EQUISIMILIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; THROMBOCYTE; THROMBOCYTE AGGREGATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIBODIES, BACTERIAL; ENDOTHELIAL CELLS; FIBRONECTINS; HUMANS; PLATELET AGGREGATION; PROTEIN BINDING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; VIRULENCE;

STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILIS;

EID: 84857994314     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.10.008     Document Type: Article

References (29)

1. Brandt C.M., Spellerberg B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin. Infect. Dis. 2009, 49:766-772.
2. Sylvetsky N., Raveh D., Schlesinger Y., Rudensky B., Yinnon A.M. Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am. J. Med. 2002, 112:622-626.
3. Liao C.H., Liu L.C., Huang Y.T., Teng L.J., Hsueh P.R. Bacteremia caused by group G Streptococci, Taiwan. Emerg. Infect. Dis. 2008, 14:837-840.
4. Cohen-Poradosu R., Jaffe J., Lavi D., Grisariu-Greenzaid S., Nir-Paz R., Valinsky L., Dan-Goor M., Block C., Beall B., Moses A.E. Group G streptococcal bacteremia in Jerusalem. Emerg. Infect. Dis. 2004, 10:1455-1460.
5. Rantala S., Vähäkuopus S., Vuopio-Varkila J., Vuento R., Syrjänen J. Streptococcus dysgalactiae subsp. equisimilis bacteremia, Finland, 1995-2004. Emerg. Infect. Dis. 2010, 16:843-846.
6. Venezio F.R., Gullberg R.M., Westenfelder G.O., Phair J.P., Cook F.V. Group G streptococcal endocarditis and bacteremia. Am. J. Med. 1986, 81:29-34.
7. Rantala S., Vuopio-Varkila J., Vuento R., Huhtala H., Syrjänen J. Clinical presentations and epidemiology of beta-haemolytic streptococcal bacteraemia: a population-based study. Clin. Microbiol. Infect. 2009, 15:286-288.
8. Tee W.S., Lieu P.K., Ngan C.C. Epidemiology of beta-haemolytic group G streptococcal bacteraemia in Singapore (1996 to 1998). Ann. Acad. Med. Singapore 2002, 31:86-91.
9. Kahn F., Linder A., Petersson A.C., Christensson B., Rasmussen M. Axillary abscess complicated by venous thrombosis: identification of Streptococcus pyogenes by 16S PCR. J. Clin. Microbiol. 2010, 48:3435-3437.
10. Schnitzler N., Podbielski A., Baumgarten G., Mignon M., Kaufhold A. M or M-like protein gene polymorphisms in human group G streptococci. J. Clin. Microbiol. 1995, 33:356-363.
11. Berge A., Sjöbring U. PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J. Biol. Chem. 1993, 268:25417-25424.
12. Rasmussen M., Müller H.P., Björck L. Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J. Biol. Chem. 1999, 274:15336-15344.
13. Rasmussen M., Johansson D., Söbirk S.K., Mörgelin M., Shannon O. Clinical isolates of Enterococcus faecalis aggregate human platelets. Microbes Infect. 2010, 12:295-301.
14. Lancefield R.C. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J. Exp. Med. 1957, 106:525-544.
15. Nerlich A., Rohde M., Talay S.R., Genth H., Just I., Chhatwal G.S. Invasion of endothelial cells by tissue-invasive M3 type group A streptococci requires Src kinase and activation of Rac1 by a phosphatidylinositol 3-kinase-independent mechanism. J. Biol. Chem. 2009, 284:20319-20328.
16. Rohde M., Müller E., Chhatwal G.S., Talay S.R. Host cell caveolae act as an entry-port for group A streptococci. Cell Microbiol. 2003, 5:323-342.
17. Rohde M., Graham R.M., Branitzki-Heinemann K., Borchers P., Preuss C., Schleicher I., Zahner D., Talay S.R., Fulde M., Dinkla K., Chhatwal G.S. Differences in the aromatic domain of homologous streptococcal fibronectin-binding proteins trigger different cell invasion mechanisms and survival rates. Cell Microbiol. 2011, 13:450-468.
18. Kittang B.R., Langeland N., Mylvaganam H. Distribution of emm types and subtypes among noninvasive group A, C and G streptococcal isolates in western Norway. Apmis 2008, 116:457-464.
19. Johansson H.M., Mörgelin M., Frick I.M. Protein FOG-a streptococcal inhibitor of neutrophil function. Microbiology 2004, 150:4211-4221.
20. Campo R.E., Schultz D.R., Bisno A.L. M proteins of group G streptococci: mechanisms of resistance to phagocytosis. J. Infect. Dis. 1995, 171:601-606.
21. Bisno A.L., Gaviria J.M. Murine model of recurrent group G streptococcal cellulitis: no evidence of protective immunity. Infect. Immun. 1997, 65:4926-4930.
22. Fitzgerald J.R., Foster T.J., Cox D. The interaction of bacterial pathogens with platelets. Nat. Rev. Microbiol. 2006, 4:445-457.
23. Sjöbring U., Ringdahl U., Ruggeri Z.M. Induction of platelet thrombi by bacteria and antibodies. Blood 2002, 100:4470-4477.
24. McCormick J.K., Tripp T.J., Dunny G.M., Schlievert P.M. Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to Enterococcus faecalis. J. Infect. Dis. 2002, 185:994-997.
25. Haidan A., Talay S.R., Rohde M., Sriprakash K.S., Currie B.J., Chhatwal G.S. Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet 2000, 356:1167-1169.
26. Switalski L.M., Ljungh å, Ryden C., Rubin K., Höök M., Wadström T. Binding of fibronectin to the surface of group A, C, and G streptococci isolated from human infections. Eur. J. Clin. Microbiol. 1982, 1:381-387.
27. Kline J.B., Xu S., Bisno A.L., Collins C.M. Identification of a fibronectin-binding protein (GfbA) in pathogenic group G streptococci. Infect. Immun. 1996, 64:2122-2129.
28. Björck L., Kastern W., Lindahl G., Widebäck K. Streptococcal protein G, expressed by streptococci or by Escherichia coli, has separate binding sites for human albumin and IgG. Mol. Immunol. 1987, 24:1113-1122.
29. Müller H.P., Rantamäki L.K. Binding of native alpha 2-macroglobulin to human group G streptococci. Infect. Immun. 1995, 63:2833-2839.